CMED Authorises Average Price Rise Of 4.6% For 2010

Brazil's Regulatory Board of the Medicine Market, CMED, has authorised an average 4.6% increase in the maximum price of medicines as part of its annual price review for 2010. Three distinct increase bands of 4.45%, 4.64% and 4.83% are defined under the latest legislation, based on levels of generic penetration for individual therapeutic classes. BMI believes that CMED's new mechanism should be viewed positively by drugmakers, owing to the above-inflation rates at which increases are

To read the full article, please choose one of the following options: